738 Safety outcomes for first-in-man intradermal injections of lentiviral-engineered COL7A1-supplemented autologous fibroblasts in adults with recessive dystrophic epidermolysis bullosa
2018
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI